Top Buy
| Security | Buy ▲ | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Smith & Nephew plc | 1 | 0 | 0 | 0 | €13.73 | - | - |
| Sarepta Therapeutics | 1 | 0 | 0 | 0 | €113.85 | €130.00 | 14.185% |
| Steris Corp. | 1 | 0 | 0 | 0 | €218.00 | - | - |
| bioMerieux S.A. | 1 | 0 | 1 | 0 | €108.10 | - | - |
| Grifols S.A. | 1 | 0 | 0 | 0 | €9.63 | - | - |
| UCB S.A. | 1 | 0 | 1 | 0 | €162.80 | €210.00 | 28.993% |
| Ipsen S.A. | 1 | 0 | 0 | 0 | €111.80 | €109.00 | -2.504% |
| AstraZeneca plc | 2 | 0 | 0 | 0 | €140.65 | €165.00 | 17.312% |
| Veeva Systems A | 2 | 0 | 0 | 0 | €192.45 | - | - |
| EssilorLuxottica SA | 3 | 0 | 1 | 0 | €203.50 | €224.50 | 10.319% |
| Smith & Nephew plc ADR | 3 | 0 | 0 | 0 | €27.40 | - | - |
| Koninklijke Philips Electronics ADR | 3 | 1 | 0 | 0 | €27.20 | - | - |
| Baxter International | 3 | 0 | 0 | 0 | €34.49 | €46.00 | 33.357% |
| Novartis AG ADR | 3 | 0 | 0 | 0 | €104.00 | €112.40 | 8.074% |
| Fresenius SE & Co. KGaA | 3 | 0 | 0 | 0 | €33.23 | - | - |
| Roche Holding AG ADR | 4 | 3 | 1 | 1 | €35.40 | €38.00 | 7.357% |
| Sanofi S.A. | 4 | 0 | 0 | 0 | €103.24 | €109.00 | 5.579% |
| Novo Nordisk A/S | 5 | 0 | 1 | 0 | €185.00 | €195.00 | 5.405% |
| GSK plc ADR | 5 | 0 | 0 | 0 | €36.60 | €49.33 | 34.773% |
| Merck KGaA | 5 | 1 | 1 | 0 | €157.65 | €172.00 | 9.102% |
| Quest Diagnostics Inc. | 7 | 0 | 0 | 0 | €139.80 | €145.02 | 3.732% |
| Medtronic plc | 7 | 1 | 2 | 0 | €80.05 | €92.55 | 15.616% |
| QuidelOrtho Corp. | 8 | 2 | 1 | 0 | €41.80 | €56.55 | 35.280% |
| Sanofi S.A. ADR | 9 | 0 | 3 | 0 | €52.50 | €55.25 | 5.246% |
| Fresenius Medical Care AG & Co KGaA ADR | 9 | 1 | 1 | 0 | €18.30 | - | - |